Scientific Library
New cancer treatment may reawaken the immune system
Cancer is a disease caused by abnormal cell growth. The cells’ genetic material is corrupted and the metabolic processes do not interact well with them anymore. They grow unchecked, mostly in the form
How can CRISPR/Cas9 be used to edit genomes?
Genes are key components of our lives. With many other factors, they contribute to shaping us, making people and any other living organism what they are. Genomes, whether human or not, are able to evolve
Unlocking the Power of Immuno-Oncology: Cutting-Edge Tools for Cancer Research
Access an exciting on-demand webinar where we dive into the latest therapeutic strategies leveraging the immune system to combat cancer, with a focus on
Enhance Your Therapeutic mRNA Research Projects with Modified NTPs
How Modified NTPs are Revolutionising mRNA Vaccine Technology
In recent years, the spotlight on mRNA (messenger RNA) technology has intensified, largely due to its pivotal role in developing COVID-19 vaccines
Optimising mRNA for Therapeutics: The Synergy of CleanCap Technology and Minimal UTRs
mRNA and UTRs: Unlocking New Frontiers in Therapeutic Innovation
Over the past five years, there has been an explosive surge in scientific interest surrounding messenger RNA (mRNA), as this small but
Revolutionising mRNA Production: When Simplicity Meets Efficiency
mRNA-Based Therapeutics: Pioneering the Future of Medicine
Over the past few years, mRNA-based therapeutics have emerged as a promising approach to treat various diseases, including cancer, infectious
Unlocking the Next Frontier in Immuno-Oncology: Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms
Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms
In the ever-evolving field of immuno-oncology, the race to develop the most effective cell-based therapies has never been more urgent—or
The Full TriLink Catalog Expertly Delivered by Tebubio
Looking for high-quality mRNA, nucleotides, and custom oligonucleotides?Tebubio delivers the complete TriLink catalogue, giving researchers easy access to industry-leading reagents.
Assessing Cellular PARylation: Convenient ELISA-Based Methods
Discover how ELISA-based methods enable precise PARylation assessment in intact cells. Learn about the role of PARP and PARG inhibitors in drug discovery and cancer research.
Explore commercial kits for
LIVE-Stepâ„¢ Cell Assay System: A Next-Generation Solution for Measuring Cell Viability
Discover the LIVE-Stepâ„¢ Cell Assay System: a fast, sensitive, and cost-effective solution for measuring cell viability in drug screening, cancer research, and toxicity studies.
Learn how this ATP-based
Bispecific Antibodies: A Revolution in Cancer Treatment
In this blog, we will delve into how BITE antibodies, are transforming cancer treatment strategies, with a special focus on the tools developed by our partner, BPS Biosciences, to help you develop and
Gamma Delta T Cells : A promising Avenue for Novel Cancer Immunotherapies
In this blog, we delve into the potential of Gamma Delta (γδ) T cells in the development of new cancer treatment, and how thanks to the tools developed by our partner BPS Bioscience we can support you